Terumo Co. (OTCMKTS:TRUMY - Get Free Report)'s stock price crossed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $19.31 and traded as low as $17.98. Terumo shares last traded at $18.11, with a volume of 92,547 shares traded.
Terumo Stock Performance
The stock has a market capitalization of $26.96 billion, a PE ratio of 39.39 and a beta of 0.64. The company's 50-day moving average price is $19.16 and its 200 day moving average price is $19.08. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.70 and a current ratio of 2.94.
Terumo (OTCMKTS:TRUMY - Get Free Report) last posted its earnings results on Thursday, February 13th. The company reported $0.16 earnings per share for the quarter. The firm had revenue of $1.73 billion for the quarter.
Terumo Company Profile
(
Get Free Report)
Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.
Featured Stories
Before you consider Terumo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Terumo wasn't on the list.
While Terumo currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
